Fast Market Access Through Operational Excellence

Executive Summary

An established international pharmaceutical company turned to Therismos to manage the operational challenges of introducing a newly acquired controlled drug to the UK market. 

By leveraging Therismos’ extensive operational licences and order-to-cash services, the client was able to generate multi-million-pound sales almost instantly, bypassing the complexities of in-house licensing and logistics. This case highlights the agility and expertise that Therismos brings to the table.

Introduction

A longstanding client of Therismos identified a significant commercial opportunity by acquiring a controlled drug product for the UK market. However, they lacked the necessary licences, infrastructure and experience to handle controlled drugs. Without these capabilities, they risked losing market momentum and sales opportunities.

Challenges/Problems

• Licensing Requirements: the client did not hold the controlled drug licences required for importation and distribution.
• Time Constraints: delays in setting up internal operations would inevitably lead to lost market share and revenue.
• Regulatory Complexity: managing controlled drugs comes with stringent regulatory obligations that the client had limited experience with.

Solution

Therismos offered a turnkey solution, handling all aspects of the operational cycle, including importation, storage, distribution and sales. With existing licences and a proven order-to-cash service model, Therismos enabled the client to quickly enter the UK wholesale market without the need for in-house capability.

Implementation

Therismos seamlessly integrated the new controlled drug into its operational framework. The team managed the entire supply chain, from importing the product to fulfilling orders and ensuring compliance with UK regulatory standards. The transition was smooth and immediate, allowing the client to focus on their core business.

Results/Outcomes

• Immediate Sales: the client generated multi-million-pound sales almost instantly, capitalising on their new acquisition.
• Cost Savings: by outsourcing operations to Therismos, the client avoided the substantial costs of establishing in-house capabilities.
• Regulatory Compliance: Therismos ensured full compliance with UK regulations, mitigating risk for the client.

Key Takeaways

This case demonstrates Therismos’ ability to provide fast, compliant and cost-effective market access solutions for pharmaceutical companies. By leveraging our operational expertise, the client achieved immediate commercial success without the burden of managing complex logistics and regulations.